Onxeo S.A.: Onxeo: Extraordinary General Meeting of February

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), hereafter "Onxeo" or the "Company", a clinical stage biotechnology company specializing in the development of innovative drugs targeting

Related Keywords

Paris , France General , France , Arthur Rouill , Onis Onxeo , Raymond Poincar , Onxeo Sa Euronext , Emmanuel Huynh , Renaissance Paris Nobel Tour Eiffel Hotel , Company Group , Regulatory News , Euronext Growth Paris , Extraordinary General Meeting , General Meeting , General Meetings , Onxeo , Xtraordinary , Eneral , Meeting , February , 023 , Availability , Preparatory , Documents ,